Molecular results are not always straightforward. CLSI M47 advises laboratories on:
For the laboratory, adhering to M47 is not just about passing accreditation—it is about diagnostic stewardship. A poorly validated PCR can lead to unnecessary antibiotics (false positive) or missed treatment (false negative). Conversely, a properly validated molecular test under M47 guidelines enables targeted therapy, reduced hospital stay, and improved antimicrobial resistance surveillance. clsi m47
It is considered essential reading for clinical microbiologists, phlebotomists, infection control practitioners, and infectious disease physicians. Molecular results are not always straightforward
In the rapidly evolving landscape of clinical microbiology, precision is not just a goal—it is a patient safety imperative. For decades, laboratories relied on phenotypic methods (culture, biochemical testing, and MALDI-TOF) to identify bacterial pathogens. However, the rise of molecular diagnostics has introduced a new era of speed and accuracy. At the heart of validating and implementing these technologies lies a critical document: . Conversely, a properly validated molecular test under M47
The guideline applies to a wide array of technologies, including: